Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in Ann Neurol Retrieve available abstracts of 92 articles: HTML format Text format

Single Articles

January 2012
1. ROSSI S , Furlan R, De Chiara V, Motta C, et al
   Interleukin-1beta causes synaptic hyperexcitability in multiple sclerosis.
   Ann Neurol. 2012;71:76-83.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. OKSENBERG JR , Hauser SL
   Decoding multiple sclerosis.
   Ann Neurol. 2011;70:A5-7.
   PubMed     Text format     Related articles   
   
   
   
   
3. PATSOPOULOS NA , de Bakker PI
   Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
   Ann Neurol. 2011;70:897-912.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. BLANKENHORN EP , Butterfield R, Case LK, Wall EH, et al
   Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis.
   Ann Neurol. 2011;70:887-96.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. RAMAGOPALAN SV , Dyment DA, Cader MZ, Morrison KM, et al
   Rare variants in the CYP27B1 gene are associated with multiple sclerosis.
   Ann Neurol. 2011;70:881-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
6. MOLL NM , Rietsch AM, Thomas S, Ransohoff AJ, et al
   Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations.
   Ann Neurol. 2011;70:764-73.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. BOZIC C , Richman S, Plavina T, Natarajan A, et al
   Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1.
   Ann Neurol. 2011;70:713-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. PONSONBY AL , Lucas RM
   Shift work and multiple sclerosis.
   Ann Neurol. 2011;70:680-3.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
9. HEDSTROM AK , Akerstedt T, Hillert J, Olsson T, et al
   Shift work at young age is associated with increased risk for multiple sclerosis.
   Ann Neurol. 2011 Oct 17. doi: 10.1002/ana.22597.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WINKELMANN A , Loebermann M, Reisinger EC, Peter Hartung H, et al
    Fingolimod treatment for multiple sclerosis Patients What Do We Do with Varicella?
    Ann Neurol. 2011;70:673-4.
    PubMed     Text format     Related articles   
    
    
    
    
11. QIAN P , Cadavid D, Wolansky LJ, Cook SD, et al
    Heterogeneity in longitudinal evolution of ring-enhancing multiple sclerosis lesions.
    Ann Neurol. 2011;70:668-9.
    PubMed     Text format     Related articles   
    
    
    
    
12. BUSTAMANTE MF , Fissolo N, Rio J, Espejo C, et al
    Implication of the toll-like receptor 4 pathway in the response to interferon-beta in multiple sclerosis.
    Ann Neurol. 2011;70:634-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
13. STEINER I
    On human disease and animal models.
    Ann Neurol. 2011;70:343-4.
    PubMed     Text format     Related articles   
    
    
    
    
14. TUMANI H , Deisenhammer F, Giovannoni G, Gold R, et al
    Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis.
    Ann Neurol. 2011;70:520.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
15. GALEA I , Freedman MS, Thompson EJ
    Cerebrospinal fluid analysis in the 2010 revised McDonald's multiple sclerosis diagnostic criteria.
    Ann Neurol. 2011;70:183.
    PubMed     Text format     Related articles   
    
    
    
    
16. CENTONZE D , Floris R, Stefanini M, Rossi S, et al
    Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity.
    Ann Neurol. 2011;70:52-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. MIRZAEI F , Michels KB, Munger K, O'Reilly E, et al
    Gestational vitamin D and the risk of multiple sclerosis in offspring.
    Ann Neurol. 2011;70:30-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CUTTER G , Salter A
    Got milk?
    Ann Neurol. 2011;70:3-4.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
19. VAN DER KOP ML , Pearce MS, Dahlgren L, Synnes A, et al
    Neonatal and delivery outcomes in women with multiple sclerosis.
    Ann Neurol. 2011 Jun 27. doi: 10.1002/ana.22483.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. LASSMANN H
    A dynamic view of the blood-brain barrier in active multiple sclerosis lesions.
    Ann Neurol. 2011 Jun 2. doi: 10.1002/ana.22494.
    PubMed     Text format     Related articles   
    
    
    
    
21. ZIVADINOV R , Ramanathan M, Dwyer MG, Marr K, et al
    Comment on "no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset".
    Ann Neurol. 2011;69:1062-3.
    PubMed     Text format     Related articles   
    
    
    
    
22. KOEL-SIMMELINK MJ , Teunissen CE, Behradkia P, Blankenstein MA, et al
    The neurofilament light chain is not stable in vitro.
    Ann Neurol. 2011;69:1065-6.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
23. KILSDONK ID , Barkhof F, Wattjes MP
    2010 revisions to mcDonald criteria for diagnosis of multiple sclerosis: Impact of 3-tesla magnetic resonance imaging.
    Ann Neurol. 2011 May 26. doi: 10.1002/ana.22490.
    PubMed     Text format     Related articles   
    
    
    
    
24. GAITAN MI , Shea CD, Evangelou IE, Stone RD, et al
    Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.
    Ann Neurol. 2011 May 11. doi: 10.1002/ana.22472.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. COHEN JA , Chun J
    Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.
    Ann Neurol. 2011;69:759-77.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
26. GIAMPIERO A
    Chronic cerebrospinal venous insufficiency and susceptibility to multiple sclerosis.
    Ann Neurol. 2011 Apr 12. doi: 10.1002/ana.22451.
    PubMed     Text format     Related articles   
    
    
    
    
27. AXTHELM MK , Bourdette DN, Marracci GH, Su W, et al
    Japanese macaque encephalomyelitis: A spontaneous multiple sclerosis-like disease in a nonhuman primate.
    Ann Neurol. 2011 Apr 7. doi: 10.1002/ana.22449.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KREMER D , Aktas O, Hartung HP, Kury P, et al
    The complex world of oligodendroglial differentiation inhibitors.
    Ann Neurol. 2011;69:602-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HAO J , Campagnolo D, Liu R, Piao W, et al
    Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
    Ann Neurol. 2011;69:721-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ZAHEDNASAB H , Bahreini SA
    Interferon-beta and toll-like receptor-9 processing.
    Ann Neurol. 2011;69:740-1.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
31. CAMPBELL GR , Ziabreva I, Reeve AK, Krishnan KJ, et al
    Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.
    Ann Neurol. 2011;69:481-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. DUTTA R , Chang A, Doud MK, Kidd GJ, et al
    Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
    Ann Neurol. 2011;69:445-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. AKTAS O , Hartung HP
    Beyond axonal transection: Hippocampal damage in multiple sclerosis.
    Ann Neurol. 2011;69:433-6.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
34. MEHLING M , Hilbert P, Fritz S, Durovic B, et al
    Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients.
    Ann Neurol. 2011;69:408-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. POLMAN CH , Reingold SC, Banwell B, Clanet M, et al
    Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
    Ann Neurol. 2011;69:292-302.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. RUDICK RA
    Diagnostic criteria in multiple sclerosis: Headed in the right direction but still a ways to go.
    Ann Neurol. 2011;69:234-6.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
37. CORREALE J , Villa A
    Role of CD8 regulatory T Cells in multiple sclerosis.
    Ann Neurol. 2011 Jan 19. doi: 10.1002/ana.22302.
    PubMed     Text format     Related articles   
    
    
    
    
38. BARACCHINI C , Perini P, Calabrese M, Causin F, et al
    No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset.
    Ann Neurol. 2011;69:90-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. GUNNARSSON M , Malmestrom C, Axelsson M, Sundstrom P, et al
    Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
    Ann Neurol. 2011;69:83-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. COMI G , Cohen JA, Arnold DL, Wynn D, et al
    Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.
    Ann Neurol. 2011;69:75-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. GOURRAUD PA , McElroy JP, Caillier SJ, Johnson BA, et al
    Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.
    Ann Neurol. 2011;69:65-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. HARDY J , Thompson AJ
    Dissecting the familial risk of multiple sclerosis.
    Ann Neurol. 2011;69:11-2.
    PubMed     Text format     Related articles   
    
    
    
    
43. COHEN R , Blight AR
    4-Aminopyridine: new life for an old drug. Reply.
    Ann Neurol. 2011;69:218-20.
    PubMed     Text format     Related articles   
    
    
    
    
44. WARNKE C , Adams O, Hartung HP, Kieseier BC, et al
    Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.
    Ann Neurol. 2011;69:215-6.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
45. KHOURY S , Bakshi R
    Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis.
    Ann Neurol. 2010;68:778-9.
    PubMed     Text format     Related articles   
    
    
    
    
46. PETZOLD A , Mondria T, Kuhle J, Rocca MA, et al
    Evidence for acute neurotoxicity after chemotherapy.
    Ann Neurol. 2010;68:806-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
47. BALASHOV KE , Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, et al
    Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. CAMPBELL GR , Ziabreva I, Reeve AK, Krishnan KJ, et al
    Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. ZAMBONI P
    Regarding "No Cerebrocervical Venous Congestion in Patients with Multiple Sclerosis. Intraluminal Jugular Septation"
    Ann Neurol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
50. GEURTS JJ , Kooi EJ, Witte ME, van der Valk P, et al
    Multiple sclerosis as an "Inside-out" disease.
    Ann Neurol. 2010;68:767-8.
    PubMed     Text format     Related articles   
    
    
    
    
51. JURYNCZYK M , Walczak A, Jurewicz A, Jesionek-Kupnicka D, et al
    Immune regulation of multiple sclerosis by transdermally applied myelin peptides.
    Ann Neurol. 2010;68:593-601.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. STEINMAN L , Zamvil SS
    Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosis.
    Ann Neurol. 2010;68:567-9.
    PubMed     Text format     Related articles   
    
    
    
    
53. DAMMANN O , Leviton A
    The challenge of causal inference.
    Ann Neurol. 2010;68:770.
    PubMed     Text format     Related articles   
    
    
    
    
54. APIWATTANAKUL M , Popescu BF, Matiello M, Weinshenker BG, et al
    Intractable vomiting as the initial presentation of neuromyelitis optica.
    Ann Neurol. 2010;68:757-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. PIORO EP , Brooks BR, Cummings J, Schiffer R, et al
    Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect.
    Ann Neurol. 2010;68:693-702.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
56. STANKOFF B , Freeman L, Aigrot MS, Chardain A, et al
    Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-(11) C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.
    Ann Neurol. 2010 Oct 29. doi: 10.1002/ana.22320.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. GUNNARSSON M , Malmestrom C, Axelsson M, Sundstrom P, et al
    Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. RASMUSSEN S , Imitola J, Ayuso-Sacido A, Wang Y, et al
    Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.
    Ann Neurol. 2010 Oct 28. doi: 10.1002/ana.22299.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. KREFT KL , Verbraak E, Wierenga-Wolf AF, Laman JD, et al
    Role of CD8 regulatory T-cells in multiple sclerosis.
    Ann Neurol. 2010 Oct 28. doi: 10.1002/ana.22288.
    PubMed     Text format     Related articles   
    
    
    
    
60. SIMKA M , Kazibudzki M
    Chronic cerebrospinal venous insufficiency and multiple sclerosis: A commentary.
    Ann Neurol. 2010;68:562-3.
    PubMed     Text format     Related articles   
    
    
    
    
61. BEGGS C
    Multiple sclerosis appears To be associated with cerebral venous abnormalities.
    Ann Neurol. 2010;68:560-1.
    PubMed     Text format     Related articles   
    
    
    
    
62. GOODMAN AD , Brown TR, Edwards KR, Krupp LB, et al
    A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
    Ann Neurol. 2010;68:494-502.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. MAGLIOZZI R , Howell OW, Reeves C, Roncaroli F, et al
    A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.
    Ann Neurol. 2010;68:477-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
64. BERGER JR , Centonze D, Comi G, Confavreux C, et al
    Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.
    Ann Neurol. 2010;68:409-11.
    PubMed     Text format     Related articles   
    
    
    
    
65. RYSCHKEWITSCH CF , Jensen PN, Monaco MC, Major EO, et al
    JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab.
    Ann Neurol. 2010;68:384-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. WEST TW , Cree BA
    Natalizumab dosage suspension: are we helping or hurting?
    Ann Neurol. 2010;68:395-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
67. ANDRODIAS G , Reynolds R, Chanal M, Ritleng C, et al
    Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. HANDEL AE , Lincoln MR, Ramagopalan SV
    Chronic cerebrospinal venous insufficiency and multiple sclerosis.
    Ann Neurol. 2010;68:270.
    PubMed     Text format     Related articles   
    
    
    
    
69. SUNDSTROM P , Wahlin A, Ambarki K, Birgander R, et al
    Venous and cerebrospinal fluid flow in multiple sclerosis: A case-control study.
    Ann Neurol. 2010;68:255-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SIMPSON S JR , Taylor B, Blizzard L, Ponsonby AL, et al
    Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
    Ann Neurol. 2010;68:193-203.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. DOEPP F , Paul F, Valdueza JM, Schmierer K, et al
    No cerebrocervical venous congestion in patients with multiple sclerosis.
    Ann Neurol. 2010;68:173-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. CREE BA , Kornyeyeva E, Goodin DS
    Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
    Ann Neurol. 2010;68:145-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
73. KILLESTEIN J , Vennegoor A, Strijbis EM, Seewann A, et al
    Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. DARLINGTON PJ , Boivin MN, Renoux C, Francois M, et al
    Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. BRAHIC M
    Multiple sclerosis and viruses.
    Ann Neurol. 2010;68:6-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. BITTNER S , Bobak N, Herrmann AM, Gobel K, et al
    Upregulation of K(2P)5.1 potassium channels in multiple sclerosis.
    Ann Neurol. 2010;68:58-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. HAUSER SL , Johnston SC
    4-aminopyridine: new life for an old drug.
    Ann Neurol. 2010;68:A8-9.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
78. LEVIN LI , Munger KL, O'Reilly EJ, Falk KI, et al
    Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
    Ann Neurol. 2010;67:824-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. TALMAN LS , Bisker ER, Sackel DJ, Long DA Jr, et al
    Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.
    Ann Neurol. 2010;67:749-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
80. RAMAGOPALAN SV , Dyment DA, Giovannoni G, Sadovnick AD, et al
    HLA-DRB1*15, low infant sibling exposure, and multiple sclerosis gene-environment interaction.
    Ann Neurol. 2010;67:694-5.
    PubMed     Text format     Related articles   
    
    
    
    
81. MORAAL B , van den Elskamp IJ, Knol DL, Uitdehaag BM, et al
    Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.
    Ann Neurol. 2010;67:667-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. CORREALE J , Villa A
    Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis.
    Ann Neurol. 2010;67:625-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. MOWRY EM , Krupp LB, Milazzo M, Chabas D, et al
    Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
    Ann Neurol. 2010;67:618-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
84. STECK A , Latov N
    Have we finally identified an autoimmune demyelinating disease?
    Ann Neurol. 2010;67:552.
    PubMed     Text format     Related articles   
    
    
    
    
85. BAR-OR A , Fawaz L, Fan B, Darlington PJ, et al
    Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Ann Neurol. 2010;67:452-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
86. CALABRESE M , Rocca MA, Atzori M, Mattisi I, et al
    A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Ann Neurol. 2010;67:376-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. KHAN O , Filippi M, Freedman MS, Barkhof F, et al
    Chronic cerebrospinal venous insufficiency and multiple sclerosis.
    Ann Neurol. 2010;67:286-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
88. VAN DER MEI IA , Ponsonby AL, Taylor BV, Stankovich J, et al
    Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: gene-environment interaction.
    Ann Neurol. 2010;67:261-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. LUNEMANN JD , Tintore M, Messmer B, Strowig T, et al
    Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.
    Ann Neurol. 2010;67:159-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. FOCOSI D
    Concerns on unpredictable pharmacokinetics and pharmacodynamics of natalizumab.
    Ann Neurol. 2010;67:270.
    PubMed     Text format     Related articles   
    
    
    
    January 2010
91. SAWCER S , Ban M, Wason J, Dudbridge F, et al
    What role for genetics in the prediction of multiple sclerosis?
    Ann Neurol. 2010;67:3-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. 
    Experimental multiple sclerosis vascular shunting procedure halted at Stanford.
    Ann Neurol. 2010;67:A13-5.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: